dimagnesium;pentane;dibromide

• 分子结构分类: 有机化合物 - 有机盐 - 有机金属盐
• 英文名称: dimagnesium;pentane;dibromide
• 化学式: C5H10Br2Mg2
• 分子量: 278.55
• InChiKey: BHNGKNROBJWJDN-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  -4.93
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  dimagnesium;pentane;dibromide 、 苯基二甲基氯硅烷 、 2,3-二溴-1-丙烯 在 ice 、 水 、 乙醚 、 盐酸 、 Brine 、 氯化镁 作用下， 以 四氢呋喃 为溶剂， 反应 16.92h， 以Column chromatography gave 1.47 g of 2-bromo-8-(phenyldimethylsilyl)-oct-1-ene as a colorless oil的产率得到2-bromo-8-(phenyldimethylsilyl)-oct-1-ene
  参考文献：
  名称：

  METHOD TO INHIBIT ETHYLENE RESPONSES IN PLANTS

  摘要：

  本发明通常涉及抑制植物和植物材料中乙烯反应的方法，特别涉及通过将植物暴露于环丙烯衍生物和其组合物中来抑制各种乙烯反应，其中：1）环丙烯环上的至少一个取代基包含一个碳环或杂环，或2）取代基包含硅、硫、磷或硼，或3）至少一个取代基含有一到四个非氢原子，且至少一个取代基含有超过四个非氢原子。

  公开号：

  US20110190137A1

文献信息

• Delivery systems for cyclopropenes
  申请人：——

  公开号：US20020198107A1

  公开（公告）日：2002-12-26

  The present invention relates to new delivery systems for cyclopropenes in which the cyclopropene, either free or encapsulated within a molecular encapsulation agent is incorporated into produce packaging materials.

  本发明涉及一种新的环丙烯递送系统，其中环丙烯，无论是自由的还是被包埋在分子封装剂中，被纳入到生产包装材料中。
• Method to inhibit ethylene responses in plants
  申请人：Jacobson Martin Richard

  公开号：US20050065033A1

  公开（公告）日：2005-03-24

  The present invention generally relates to methods of inhibiting ethylene responses in plants and plant materials, and particularly relates to methods of inhibiting various ethylene responses including plant maturation and degradation, by exposing plants to cyclopropene derivatives and compositions thereof wherein: 1) at least one substituent on the cyclopropene ring contains a carbocyclic or heterocyclic ring, or 2) . a substituent contains silicon, sulfur, phosphorous, or boron, or 3) least one substituent contains from one to four non-hydrogen atoms and at least one substituent contains more than four non-hydrogen atoms.

  本发明通常涉及抑制植物和植物材料中乙烯反应的方法，特别涉及通过将植物暴露于环丙烯衍生物和其组合物中来抑制各种乙烯反应，其中：1）环丙烯环上的至少一个取代基包含一个碳环或杂环，或2）一个取代基含有硅、硫、磷或硼，或3）至少一个取代基含有一个到四个非氢原子，且至少一个取代基含有超过四个非氢原子。
• Amide compounds and use of the same
  申请人：Takeda Pharmaceutical Company Limited

  公开号：US08329691B2

  公开（公告）日：2012-12-11

  A renin inhibitor comprising a compound represented by the formula: wherein each symbol is as defined in the description, or a salt thereof or a prodrug thereof. The compound of the present invention has a superior renin inhibitory activity, and thus is useful as an agent for the prophylaxis or treatment of hypertension, various organ damages attributable to hypertension and the like.

  一种肾素抑制剂，包括由下式表示的化合物：其中每个符号如描述中所定义，或其盐或前药。本发明的化合物具有优异的肾素抑制活性，因此可用作预防或治疗高血压、由高血压引起的各种器官损伤等的药剂。
• Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use
  申请人：Paras Nick A.

  公开号：US20130040931A1

  公开（公告）日：2013-02-14

  The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I); wherein ring A, B 1 , B 2 , B 3 , L, R 1 , R 2 , ring Z, m and n of Formula I are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease (AD), cognitive deficits, cognitive impairment, schizophrenia and other central nervous system conditions related to and/or caused by the formation and/or deposition of plaque on the brain. The invention also comprises further embodiments of Formula (I), intermediates and processes useful for the preparation of compounds of Formula (I).

  本发明涉及一种新的化合物类别，用于调节Beta-分泌酶酶活性和治疗Beta-分泌酶介导的疾病，包括阿尔茨海默病（AD）和相关病症。在一种实施例中，所述化合物具有通式（I）；其中，通式I中的环A、B1、B2、B3、L、R1、R2、环Z、m和n定义如下。本发明还包括将这些化合物用于制备治疗、预防或治疗与Beta-分泌酶蛋白活性相关的疾病和病症的药物组合物。这些疾病包括阿尔茨海默病（AD）、认知缺陷、认知障碍、精神分裂症和其他与大脑斑块形成和/或沉积相关和/或由此引起的中枢神经系统疾病。本发明还包括通式（I）的进一步实施例、中间体和用于制备通式（I）化合物的方法。
• Amino heteroaryl compounds as beta-secretase modulators and methods of use
  申请人：Paras Nick A.

  公开号：US08735384B2

  公开（公告）日：2014-05-27

  The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I); wherein ring A, B1, B2, B3, L, R1, R2, ring Z, m and n of Formula I are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease (AD), cognitive deficits, cognitive impairment, schizophrenia and other central nervous system conditions related to and/or caused by the formation and/or deposition of plaque on the brain. The invention also comprises further embodiments of Formula (I), intermediates and processes useful for the preparation of compounds of Formula (I).

  本发明涉及一种新的化合物类别，其可用于调节Beta-分泌酶酶活性并用于治疗Beta-分泌酶介导的疾病，包括阿尔茨海默病（AD）和相关疾病。在一种实施例中，所述化合物具有一般式（I）；其中，式I中的环A、B1、B2、B3、L、R1、R2、环Z、m和n已在此定义。本发明还包括这些化合物在制药组合物中的使用，用于治疗与beta-分泌酶蛋白活性相关的障碍和疾病，例如阿尔茨海默病（AD）、认知缺陷、认知障碍、精神分裂症和其他与大脑斑块的形成和/或沉积相关和/或由其引起的中枢神经系统疾病。本发明还包括式（I）的进一步实施例、中间体和用于制备式（I）化合物的有用过程。